Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial Academic Article Article uri icon

Overview

MeSH Major

  • Cardiovascular Diseases
  • Depressive Disorder
  • Electroconvulsive Therapy

abstract

  • GlaxoSmithKline.

publication date

  • July 2012

Research

keywords

  • Academic Article

Identity

Digital Object Identifier (DOI)

  • 10.1016/S0140-6736(12)60868-X

PubMed ID

  • 22735384

Additional Document Info

start page

  • 358

end page

  • 65

volume

  • 380

number

  • 9839